Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $145,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $75,000 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $55,000 | da $36,000 | da $140,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Anemia aplastica. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Anemia aplastica e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Anemia aplastica.
Il medico è uno specialista leader nel trattamento del cancro al seno, con un'ampia formazione ed esperienza. Ha completato la sua formazione e tirocinio presso il Centro Medico dell'Università Yonsei in Corea del Sud e ha lavorato come chirurgo presso il Centro Tumori Yonsei.<\/p>
Dal 2011 al 2013, ha servito come professore consulente nel dipartimento di cancro al seno presso l'Università di Anderson negli Stati Uniti. La sua ricerca si concentra sul trattamento del cancro al seno utilizzando farmaci ormonali e chemioterapici.<\/p>
Il medico è membro dell'Associazione Medica Coreana, della Società Americana di Oncologia Clinica e dell'Associazione Americana per la Ricerca sul Cancro.<\/p>
Il medico è un pediatra ed ematologo specializzato nel trattamento della leucemia e dell'anemia aplastica. È esperto nell'esecuzione di trapianti di midollo osseo per bambini. Il medico ha completato i suoi studi presso la Seoul National University e ha acquisito esperienza come Professore Assistente nel Dipartimento di Pediatria del Samsung Medical Center. Ha approfondito la sua esperienza come Ricercatore presso l'Università dell'Indiana. Dal 2011, contribuisce al dipartimento di pediatria del Samsung Medical Center.<\/p>
Il medico è un ematologo-oncologo altamente esperto con oltre 26 anni di esperienza nel campo. Specializzato nel trattamento del cancro del colon, dell'oncologia ematologica, dei mielomi e dei linfomi, il medico è competente in procedure avanzate come il trapianto di midollo osseo, inclusi i trapianti da donatori alternativi e non compatibili.<\/p>
Con un forte background accademico, il medico possiede un M.D. dal College of Medicine dell'Università Yonsei e un Ph.D. dal College of Medicine dell'Università Sungkyunkwan. Il medico è anche membro di numerose società professionali e ha contribuito al campo attraverso numerose pubblicazioni di articoli.<\/p>
South Korean medical centers treat severe aplastic anemia with hematopoietic stem cell transplantation (HSCT) and intensive immunosuppressive therapy (IST). Younger patients often receive allogeneic bone marrow transplantation from matched siblings. Older patients or those without donors utilize drug regimens combining antithymocyte globulin with cyclosporine and eltrombopag.
Bookimed Expert Insight: Korea's infrastructure is uniquely suited for complex hematology due to its high-volume digitalized centers. Asan Medical Center alone performs over 65,000 operations annually and maintains a 90% success rate in organ transplants. This volume translates to highly refined protocols for preventing infections during the vulnerable weeks following bone marrow replacement.
Patient Consensus: Patients note it's important to start HLA testing immediately because Korea's donor registry is highly efficient. Many emphasize the need to arrange long-term housing near the hospital for the 3-to-6 month recovery period.
South Korea manages the horse ATG shortage by using rabbit-derived anti-thymocyte globulin as the primary immunosuppressive therapy. Hospitals combine rabbit ATG with cyclosporine and methylprednisolone. Major centers also integrate eltrombopag to improve blood cell counts. Bone marrow transplantation serves as the definitive curative alternative.
Bookimed Expert Insight: Korea's heavy investment in digital infrastructure at centers like Seoul National University Bundang Hospital ensures precise long-term monitoring. Since over 50% of Korean patients require more than one year to respond to rabbit ATG, these digital tracking systems are vital for adjusting therapy. Hospitals like Asan Medical Center, performing over 65,000 surgeries annually, often transition patients to transplant quickly if immunosuppression doesn't show early promise.
Patient Consensus: Patients note it is important to prepare for a longer medical journey than expected. Practical focus often shifts toward finding specialized hematologists in Seoul who can manage the extended follow-up care required for rabbit-based regimens.
Korean medical centers report a 95% 5-year overall survival rate for severe aplastic anemia using bone marrow transplantation. This success rate applies to patients receiving tissue from HLA-identical sibling donors. These outcomes exceed survival rates of 70% typically observed with immunosuppressive therapy protocols.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and holds KOIHA accreditation for safety. This high volume allows for ultra-specialization in complex donor matching and conditioning. Our data shows that centers with these certifications maintain consistency in 5-year survival reporting.
Patient Consensus: Visitors suggest that the administrative speed in Seoul helps reduce wait times for transplant. Many note that clear communication about donor compatibility from the start reduces stress during recovery.
Korean hospitals are highly prepared for international aplastic anemia patients. Major centers like Samsung Medical Center provide dedicated international departments with coordinators and translators. These facilities combine high transplantation volumes with Joint Commission International accreditation to ensure safety for foreign nationals seeking complex hematologic care.
Bookimed Expert Insight: The data shows a powerful link between high patient volume and successful outcomes in Seoul. Asan Medical Center manages over 10,000 daily outpatients and handles nearly half of the nation's transplants. This massive clinical experience often leads to improved protocols and lower rejection rates for complex aplastic anemia cases.
Patient Consensus: Patients highlight that using hospital international desks helps prevent most logistical issues. They also recommend preparing medical record translations early to avoid delays in starting treatment after arrival.
International patients should plan for a 90-day stay in South Korea for a bone marrow transplant. This timeframe covers a 7-day diagnostic phase and 3 to 6 weeks of sterile hospitalization. Patients must remain near the hospital for 60 days of post-discharge monitoring to manage recovery.
Bookimed Expert Insight: While major centers like Asan Medical Center and Samsung Medical Center serve over 2,000,000 patients yearly, their high volume means isolation beds are tightly scheduled. If you miss your conditioning window, you might wait weeks for the next available sterile bed. Always confirm your bed reservation before booking flights, as these facilities maintain nearly 100% occupancy for transplant units.
Patient Consensus: Patients note it is vital to secure housing within 15 minutes of the hospital because post-discharge fatigue makes even short trips difficult. They also suggest planning for a 4 to 6-month stay to account for the slow recovery of the immune system.